Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

N6-cyclopentyl-3'-substituted-xylofuranosyladenosines: a new class of non-xanthine adenosine A1 receptor antagonists.

Van Calenbergh S, von Frijtag Drabbe Künzel JK, Blaton NM, Peeters OM, Rozenski J, Van Aerschot A, De Bruyn A, De Keukeleire D, IJzerman AP, Herdewijn P.

J Med Chem. 1997 Nov 7;40(23):3765-72.

PMID:
9371242
2.

Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.

Maemoto T, Finlayson K, Olverman HJ, Akahane A, Horton RW, Butcher SP.

Br J Pharmacol. 1997 Nov;122(6):1202-8.

3.

N6,C8-distributed adenosine derivatives as partial agonists for adenosine A1 receptors.

Roelen H, Veldman N, Spek AL, von Frijtag Drabbe Künzel J, Mathôt RA, IJzerman AP.

J Med Chem. 1996 Mar 29;39(7):1463-71.

PMID:
8691477
4.

5'-substituted adenosine analogs as new high-affinity partial agonists for the adenosine A1 receptor.

van der Wenden EM, Carnielli M, Roelen HC, Lorenzen A, von Frijtag Drabbe Künzel JK, IJzerman AP.

J Med Chem. 1998 Jan 1;41(1):102-8.

PMID:
9438026
5.

5'-O-alkyl ethers of N,2-substituted adenosine derivatives: partial agonists for the adenosine A1 and A3 receptors.

van Tilburg EW, van der Klein PA, von Frijtag Drabbe Künzel J, de Groote M, Stannek C, Lorenzen A, IJzerman AP.

J Med Chem. 2001 Aug 30;44(18):2966-75.

PMID:
11520205
6.

1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cells.

Belardinelli L, Shryock JC, Zhang Y, Scammells PJ, Olsson R, Dennis D, Milner P, Pfister J, Baker SP.

J Pharmacol Exp Ther. 1995 Dec;275(3):1167-76.

PMID:
8531078
7.

5'-Deoxy congeners of 9-(3-amido-3-deoxy-beta-D-xylofuranosyl)-N(6)-cyclopentyladenine: new adenosine A(1) receptor antagonists and inverse agonists.

Van Calenbergh S, Link A, Fujikawa S, de Ligt RA, Vanheusden V, Golisade A, Blaton NM, Rozenski J, IJzerman AP, Herdewijn P.

J Med Chem. 2002 Apr 25;45(9):1845-52.

PMID:
11960496
8.

N6,5'-Disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor.

van Tilburg EW, von Frijtag Drabbe Künzel J, de Groote M, Vollinga RC, Lorenzen A, IJzerman AP.

J Med Chem. 1999 Apr 22;42(8):1393-400.

PMID:
10212125
9.

New 2,N6-disubstituted adenosines: potent and selective A1 adenosine receptor agonists.

Hutchinson SA, Baker SP, Scammells PJ.

Bioorg Med Chem. 2002 Apr;10(4):1115-22.

PMID:
11836122
10.

Structure-activity relationships in a series of 8-substituted xanthines as A1-adenosine receptor antagonists.

Strappaghetti G, Corsano S, Barbaro R, Giannaccini G, Betti L.

Bioorg Med Chem. 2001 Mar;9(3):575-83.

PMID:
11310591
11.

8-Azaxanthine derivatives as antagonists of adenosine receptors.

Franchetti P, Messini L, Cappellacci L, Grifantini M, Lucacchini A, Martini C, Senatore G.

J Med Chem. 1994 Sep 2;37(18):2970-5.

PMID:
8071944
12.

Pharmacological characterization of a simple behavioral response mediated selectively by central adenosine A1 receptors, using in vivo and in vitro techniques.

Marston HM, Finlayson K, Maemoto T, Olverman HJ, Akahane A, Sharkey J, Butcher SP.

J Pharmacol Exp Ther. 1998 Jun;285(3):1023-30.

13.

2-Nitro analogues of adenosine and 1-deazaadenosine: synthesis and binding studies at the adenosine A1, A2A and A3 receptor subtypes.

Wanner MJ, Von Frijtag Drabbe Künzel JK, Ijzerman AP, Koomen GJ.

Bioorg Med Chem Lett. 2000 Sep 18;10(18):2141-4.

PMID:
10999489
14.

Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions.

Kim SA, Marshall MA, Melman N, Kim HS, Müller CE, Linden J, Jacobson KA.

J Med Chem. 2002 May 23;45(11):2131-8.

PMID:
12014951
15.

Ribose-modified adenosine analogues as potential partial agonists for the adenosine receptor.

van der Wenden EM, von Frijtag Drabbe Künzel JK, Mathôt RA, Danhof M, IJzerman AP, Soudijn W.

J Med Chem. 1995 Sep 29;38(20):4000-6.

PMID:
7562934
16.

8-substituted adenosine and theophylline-7-riboside analogues as potential partial agonists for the adenosine A1 receptor.

Van der Wenden EM, Hartog-Witte HR, Roelen HC, von Frijtag Drabbe Künzel JK, Pirovano IM, Mathôt RA, Danhof M, Van Aerschot A, Lidaks MJ, IJzerman AP, et al.

Eur J Pharmacol. 1995 Aug 15;290(3):189-99.

PMID:
7589213
17.

1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.

Hayallah AM, Sandoval-Ramírez J, Reith U, Schobert U, Preiss B, Schumacher B, Daly JW, Müller CE.

J Med Chem. 2002 Mar 28;45(7):1500-10.

PMID:
11906291
18.

De novo analysis of receptor binding affinity data of 8-ethenyl-xanthine antagonists to adenosine A1 and A2a receptors.

Dalpiaz A, Gessi S, Varani K, Borea PA.

Arzneimittelforschung. 1997 May;47(5):591-4.

PMID:
9205770
19.

Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists.

van Muijlwijk-Koezen JE, Timmerman H, Vollinga RC, Frijtag von Drabbe Künzel J, de Groote M, Visser S, IJzerman AP.

J Med Chem. 2001 Mar 1;44(5):749-62.

PMID:
11262085
20.

Competition of adenine nucleotides for a 1,3-[3H]-dipropyl-8-cyclopentylxanthine binding site in rat vas deferens.

Smith AD, Cheek DJ, Buxton IL, Westfall DP.

Clin Exp Pharmacol Physiol. 1997 Jul;24(7):492-7.

PMID:
9248666
Items per page

Supplemental Content

Write to the Help Desk